GLP-1 Coverage & Costs in Texas (2026)
$79/month (Embody, compounded semaglutide, monthly plan) is the lowest monthly-plan price we have recorded among the programs on this page. Embody lists 48 states and our records do not name them, so confirm Texas at intake.
The lowest recorded compounded tirzepatide price is $129/month (Embody, monthly plan). Among programs recorded as available in all 50 states, the lowest is $139/month (AgelessRx, compounded semaglutide, monthly plan). 6 of the 49 programs listed have no recorded price. Recorded prices cover medication and known program fees, not a verified total.
Texas Medicaid Coverage for GLP-1
Medicaid: not covered as of January 2026 (KFF)
KFF's map lists Texas as not covering GLP-1s for obesity under fee-for-service as of January 2026. KFF notes the state reported covering one or more weight-loss drugs, but no GLP-1s. Rules and later changes are not on that map, so confirm with the state Medicaid agency or your plan.
- Source: KFF, Medicaid Coverage of and Spending on GLP-1s, Figure 1 (January 16, 2026). Read 2026-11-06.
Your Options in Texas:
- Telehealth programs: recorded compounded prices from $79/month on a monthly plan, where the program serves Texas
- Commercial or employer insurance: check your plan's drug list and prior authorization rules
- Medicare GLP-1 Bridge for eligible Part D enrollees (see below)
Texas Medicaid GLP-1 Prescriptions in 2025
172,203
#17
$172.7 million
Ozempic
Texas Medicaid paid for 172,203 GLP-1 prescriptions in 2025, 1.5% of the 11.26 million paid nationally and number 17 of 51 (50 states and DC). It reimbursed pharmacies $172.7 million before manufacturer rebates, about $1,003 per prescription, and the most-filled product was Ozempic. These counts include diabetes prescriptions, not only weight loss. Wegovy, Zepbound and Saxenda, the brands approved for chronic weight management, made up 4,986 of those prescriptions (2.9%). Wegovy and Zepbound also carry other approved uses, so this is an upper bound on weight-loss use, not a count of it.
From 2021 to 2025, Texas Medicaid GLP-1 prescriptions went from 64,930 to 172,203, 2.7 times the 2021 count. From 2024 to 2025 the count rose by 24,307.
64,930
99,228
147,368
147,896
172,203
| Product | TX Medicaid prescriptions, 2025 | Share |
|---|---|---|
| Ozempic | 92,318 | 53.6% |
| Mounjaro | 48,744 | 28.3% |
| Trulicity | 20,578 | 11.9% |
| Wegovy | 4,638 | 2.7% |
| Rybelsus | 2,874 | 1.7% |
| Liraglutide (generic) | 1,345 | 0.8% |
| Victoza | 1,083 | 0.6% |
| Zepbound | 348 | 0.2% |
| Bydureon | 275 | 0.2% |
Source: CMS State Drug Utilization Data, 2025 (updated July 13, 2026), fee-for-service and managed care, all four quarters, compiled in our network's PriceTracker GLP-1 state table (read October 4, 2026); 2021 to 2024 summed by us from CMS's own yearly datasets with the same method, read November 9, 2026. CMS hides rows under 11 prescriptions, so small counts are slightly low. CMS publishes no per-enrollee rate here, so a total reflects the size of the program as much as use.
Texas Employee Plan and Insurer GLP-1 Rules
HealthSelect of Texas (ERS state employee plan)
Does not cover GLP-1s for weight lossThe HealthSelect of Texas plan document effective September 1, 2026 excludes prescription drugs for reducing obesity or weight, even with other health conditions. The exclusion does not apply to the plan's Wondr and Real Appeal weight programs.
The HealthSelect of Texas Master Benefit Plan Document effective September 1, 2026 lists weight-reduction prescription drugs among its exclusions.
“services or supplies for reduction of obesity or weight, including surgical procedures and prescription drugs, even if the Participant has other health conditions which might be helped by a reduction of obesity or weight, except for healthy diet counseling and obesity screening/counseling as may be provided under Preventive Care Services.”
Source: HealthSelect of Texas (Blue Cross and Blue Shield of Texas). Read October 29, 2026.
The same document carves the plan's Wondr and Real Appeal weight programs out of that exclusion.
“This exclusion does not apply to: Covered HealthSelect weight loss programs, currently Wondr and Real Appeal;”
Source: HealthSelect of Texas (Blue Cross and Blue Shield of Texas). Read October 29, 2026.
Blue Cross and Blue Shield of Texas
Covers with limitsBlue Cross and Blue Shield of Texas treats GLP-1 weight-management coverage as an optional choice for employer groups. From November 1, 2026, self-funded groups with Prime Therapeutics that cover these drugs can set a $150 member cost share for up to a 30-day supply.
A May 2025 provider notice says weight-management GLP-1s are not a standard benefit, though some self-funded (ASO) groups add them.
“Coverage for GLP-1 weight management drugs, such as Saxenda, Wegovy and Zepbound, is not a standard benefit for members. Some ASO group plans may offer coverage for weight loss and/or weight management drugs as a custom benefit.”
Source: Blue Cross and Blue Shield of Texas. Read October 29, 2026.
In a May 20, 2026 note for self-funded groups, Blue Cross and Blue Shield of Texas says GLP-1 weight-management coverage is optional for the plan.
“As with other GLP‑1s for weight management, plan coverage is optional with utilization management and metabolic health programs are available to drive safe and clinically appropriate use.”
Source: Blue Cross and Blue Shield of Texas. Read October 29, 2026.
An October 9, 2026 employer notice adds a $150 member cost-share option from November 1, 2026 for self-funded groups that cover these drugs.
“Beginning Nov. 1, 2026, self-funded groups with Prime Therapeutics® that cover GLP-1 weight-management drugs can elect a new, $150 member cost-share benefit.”
Source: Blue Cross and Blue Shield of Texas. Read October 29, 2026.
Comparing self-pay programs in Texas?
2-minute quiz: filter by budget and medication preference.
Telehealth Programs to Check for Texas
We list 49 programs here. 21 are recorded as available in all 50 states. 7 more publish their own state list, summarized below for Texas. The rest record a state count without naming the states, so confirm Texas with the program at intake before you pay.
What Programs' Own Pages Say About Texas
8 of the 8 programs whose own pages name the states they serve include Texas: Willow, SnagRx, Strut Health, MangoRx, Wellorithm, MEDGm, TelosRx, Trimi. Pages read November 9, 2026. This is what each seller states about availability, not a licensing check.
| Program | Texas |
|---|---|
| Willow | Serves TX |
| SnagRx | Serves TX |
| Strut Health | Ships to TX |
| MangoRx | Ships to TX |
| Wellorithm | Serves TX |
| MEDGm | Serves TX |
| TelosRx | Serves TX |
| Trimi | Serves TX |
Trimi's state table lists Texas as served through the Arora Health network. Visit format there: Online intake reviewed by a licensed provider; no in-person visit required. The telehealth law it cites for Texas is Tex. Occ. Code § 111.005. That citation is Trimi's, not our legal reading. Trimi state table, read November 9, 2026.
Programs on Our List, in Published Order
Compounded GLP-1 care with one-month and prepaid plans
Personalized GLP-1 consultations with tailored prescriptions and ongoing physician support
Affordable compounded semaglutide from $119/mo with free shipping and health coaching
Personalized GLP-1 weight loss with licensed providers and nationwide coverage
45 more programs on our list: 19 recorded as available in all 50 states, 7 with a state list shown in the table above, and 19 with a state count but no published list we have read. Compare all of them side by side.
Estimated GLP-1 Costs in Texas
Telehealth (Compounded)
$79 to $399/moRecorded monthly-plan prices for compounded semaglutide and tirzepatide. Availability varies by program, so confirm your state at intake.
Wegovy
Brand prices with and without insurance.
Zepbound
List, LillyDirect and savings card prices.
No insurance
Self-pay GLP-1 options without coverage.
The compounded range is our recorded monthly-plan prices, the same in every state. Brand and insurance costs depend on the plan, so we link the pages that carry their sources. Compounded medications are not FDA-approved.
Medicare Part D GLP-1 Claims in Texas, 2024
Texas prescribers wrote 1,811,427 Medicare Part D GLP-1 claims in 2024, number 2 of 51, with $2.39 billion in gross drug cost before rebates. Ozempic led with 912,298 claims for 184,703 enrollees. Wegovy had 9,114 claims. Part D did not pay for weight loss alone in 2024, so these fills are for diabetes and other approved uses.
| Product | TX Part D claims | Enrollees |
|---|---|---|
| Ozempic | 912,298 | 184,703 |
| Mounjaro | 491,789 | 90,686 |
| Trulicity | 262,491 | 56,893 |
| Rybelsus | 101,999 | 28,093 |
| Bydureon Bcise | 18,424 | 4,617 |
| Victoza | 12,711 | Not given |
| Wegovy | 9,114 | 2,523 |
| Liraglutide | 2,000 | 875 |
| Byetta | 601 | 183 |
Source: CMS Medicare Part D Prescribers by Geography and Drug, 2024 (updated May 21, 2026), state rows, read November 9, 2026. The state is the prescriber's. Claims include refills, and enrollees are not added across products because one person can fill two.
Medicare GLP-1 Bridge Program in Texas
The Bridge is national, so the rules are the same in Texas as everywhere: eligible Part D enrollees pay $50/month for Foundayo, Wegovy or Zepbound KwikPen, subject to BMI rules and exclusions. Medicare fact sheet.
$50/mo
July 1, 2026
Dec 31, 2027
How Texas Compares to Other South States
Medicaid coverage of GLP-1s for obesity is optional for states, so the answer differs by state. Here is how Texas and its neighbors in the South are recorded:
| State | Medicaid and GLP-1s for obesity | Medicaid GLP-1 Rx, 2025 |
|---|---|---|
| Texas (this page) | Not covered | 172,203 |
| Arkansas | Not covered | 24,039 |
| Louisiana | Not covered | 230,117 |
| Mississippi | Covered, January 2026 (KFF) | 61,646 |
| Oklahoma | Not covered | 82,353 |
Our recorded telehealth prices are not state-specific: $79 to $399/month on monthly plans. Medicaid and marketplace coverage is what varies.
KFF counted 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service as of January 2026. Managed care plans may differ. Later counts may be lower: The RX Index, an independent tracker, listed 11 in a July 10, 2026 snapshot and says that is not a current national count. Sources read November 6, 2026. Policies change, so confirm with your state Medicaid agency or plan.
GLP-1 Guides for Texas Cities
If Your Insurance Denies GLP-1 Coverage in Texas
Commercial plans offer an internal appeal, then external review; Texas Medicaid enrollees can ask for a fair hearing. The denial letter names the deadlines.
How to Check Your Specific Plan in Texas
- Texas Medicaid: Medicaid: not covered as of January 2026 (KFF). Ask your Medicaid plan for its drug list and prior authorization rules, or find the state agency on Medicaid.gov's state contacts.
- State employees: HealthSelect of Texas (ERS state employee plan), does not cover glp-1s for weight loss per the documents cited above. Confirm with the plan before you fill a prescription.
- Insurers on record for Texas: Blue Cross and Blue Shield of Texas. Each still depends on whether your employer bought the weight-loss benefit.
- Any other plan: call the number on your card and ask whether Wegovy or Zepbound is covered for weight loss, which tier it sits on, and what prior authorization needs. Get the answer in writing.
Find the Right GLP-1 Provider in Texas
Answer a few questions and we'll match you with the best GLP-1 program for your budget, insurance, and goals in Texas.
Frequently Asked Questions — Texas
Does Texas Medicaid cover GLP-1 medications for weight loss?
How many GLP-1 prescriptions did Texas Medicaid pay for in 2025?
How many Medicare Part D GLP-1 claims were there in Texas in 2024?
Does the Texas state employee health plan cover GLP-1s for weight loss?
What is the cheapest way to get GLP-1 medication in Texas?
Which online GLP-1 programs serve Texas?
Does Medicare cover GLP-1s in Texas?
Ready to start?
Compare the recorded costs, sources and evidence gaps for 52 listed providers. Confirm current terms with the provider before enrolling.